SIG Programme
A summary of SIG themes and locations is below, followed by an in depth programme for each.
All are welcome at these early morning sessions.
SIG Session | Day & Time | Location |
|---|---|---|
Cognitive | Thur 7 | 0745 | Hall 1 |
Sustainability | Thur 7 | 0745 | Hall 4 |
Neuro-oncology | Thur 7 | 0745 | Hall 5 |
Vestibular | Thur 7 | 0745 | Hall 7 |
Myasthenia Gravis | Fri 8 | 0750 | Hall 1 |
Sleep | Fri 8 | 0750 | Hall 4 | Sponsored by Bioproject |
Autonomic | Fri 8 | 0750 | Hall 5 |
FND | Fri 8 | 0750 | Hall 7 |
Thur 7 | 0745
Prof Hugh Markus, Cambridge (30 min): Small Vessel Disease and White Matter Injury: Mechanisms, Markers, and Risk of Cognitive Decline. WMH burden, lacunes, microstructural injury, perfusion & glymphatic pathways – Prognostic markers for MCI and dementia progression
Prof David Werring, UCL (30 min): Microbleeds, CAA, and Mixed Dementia: Interpreting Imaging for Cognitive Outcomes. – Microbleeds, superficial siderosis, CAA, and dementia risk – Interaction with AD pathology and relevance to DMT eligibility
Combined Q&A / Clinical Cases (25 min) – Real cases from cognitive and stroke clinics
Closing Summary (5 min) Key clinical messages and implications for UK memory and neurology pathways.
How to engage with action and nature
Dr James Bashford, neurologist, author of Nature Within: 20 minutes talk on his book
Dr Elaine Mulcahy, Director UK Health Alliance on Climate Change: 20 minutes talk on role of UKHACC
20 minutes group discussion on how to engage with individual, trust, ICS, national and political levels
Novel therapies for tumour related epilepsies
07.45-07.50 Welcome
07.50-08.10 Mark Cunningham, Trinity College, Dublin: Hacking the brain's accelerator- Novel therapies for Brain tumour related Epilepsy (BTRE)
08.10-08.30 Satheesh Ramalingham, QEHB, Birmingham: Are you sure it's a tumour? - Radiologically challenging lesions
08.30-08.45 Jeremy Rees, UCLH, London: SMART syndrome - Identification and novel treatments
Awaiting Programme
Fri 8 | 0750
Evolving treatment landscape in Myasthenia with special emphasis on ocular MG, real-world evidence of Rituximab and MG/FND overlap
Dr Channa Hewamadduma, Sheffield
Dr Jennifer Spillane, NHNN, London
Prof Saiju Jacob, Birmingham
Dr Sui Wong, Moorfields, London
Dr Jan Coebergh, St George's, London
Practical discussion based on case histories with presentation of new evidence.
We will have 3-4 talks of 10-15 minutes, with ample time for discussion.
Bringing sleep neurologists together
Introduction and Welcome: Siew Wong, Royal Hallamshire Hospital, Shefield & Sean J Slaght, Wessex Neurological Centre, Southampton
Restless legs syndrome/Period Limb Movement Disorder - divergent guidelines and implication for practice in the modern era of too many referrals, too few neurologists: Paul Zeun, Consultant Neurologist, University Hospitals Southampton
Demystifying sleep tests and when to use them - helping general neurologists decide whether sleep tests are clinically useful: James Alix, consultant neurophysiologist, Sheffield Teaching Hospitals
What do we want from a Sleep SIG? Siew Wong & Sean Slaght
Managing Autonomic Disorders Outside An Autonomic Unit: Lessons Learned from a National Autonomic Multidisciplinary Team Meeting
Novel Causes of Autonomic Failure: An Update
Dr Gordon Ingle
Dr Valeria Iodice
Dr Patricia McNamara
Dr Giacomo Chiara
How can we best explain aetiology in FND to patients? How can we use research to best explain a biopsychosocial formulation? Panel and group discussion.
Three 15 minute talks by:
Mahinda Yogarajah
Markus Edwards
Chrissie Burness
Using research in FND in a 'bench to bedside' approach: how research can be used to explain better explain FND aetiology and manifestations to patients. Covering functional seizures and interoception, speech patterns and functional cognitive disorders and FND changes in pregnancy.
Email the ABN
Email the Conference Team
abn@phproductionservices.co.uk
Call the ABN
44 (0) 20 7405 4060